Shilpa Medicare Gains on EMA Nod for Rivaroxaban Orodispersible Films
(Udaipur Kiran News): Shares of Shilpa Medicare climbed over 2% in Tuesday’s trade after the company received initial authorization from the European Medicines Agency (EMA) for its Rivaroxaban Orodispersible Films. The stock was trading at ₹839.65, up 2.74%, compared to its previous close of ₹817.25 on the BSE. It opened at ₹823.00 and touched an … Read more
